Symbols / SOLV Stock $74.41 -0.92% Solventum Corporation

Healthcare • Medical Instruments & Supplies • United States • NYQ
SOLV (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO —
Exch · Country NYQ · United States
Market Cap 12.89B
Enterprise Value 17.73B
Income 1.43B
Sales 8.26B
FCF (ttm) 378.50M
Book/sh 29.10
Cash/sh 3.24
Employees 20,584
Insider 10d —
IPO Mar 26, 2024
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 9.11
Forward P/E 10.57
PEG 1.22
P/S 1.56
P/B 2.56
P/C —
EV/EBITDA 15.78
EV/Sales 2.15
Quick Ratio 0.52
Current Ratio 1.07
Debt/Eq 106.46
LT Debt/Eq —
EPS (ttm) 8.17
EPS next Y 7.04
EPS Growth -91.00%
Revenue Growth -3.00%
EPS Gr Q/Q -90.50%
Rev Gr Q/Q —
Earnings (next) 2026-05-05
Earnings (prior) 2026-05-05
ROA 2.75%
ROE 34.79%
ROIC —
Gross Margin 53.65%
Oper. Margin 5.58%
Profit Margin 17.33%
Shs Outstand 173.17M
Shs Float 146.98M
Insider Own 15.04%
Instit Own 75.41%
Short Float 4.33%
Short Ratio 4.49
Short Interest 6.38M
52W High 88.20
vs 52W High -15.63%
52W Low 62.38
vs 52W Low 19.29%
Beta 0.66
Impl. Vol. 56.64%
Rel Volume 1.37
Avg Volume 1.39M
Volume 1.91M
Target (mean) $81.08
Tgt Median $82.00
Tgt Low $60.00
Tgt High $100.00
# Analysts 12
Recom Hold
Prev Close $75.10
Price $74.41
Change -0.92%
About

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$81.08
Mean price target
2. Current target
$74.41
Latest analyst target
3. DCF / Fair value
$39.34
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$74.41
Low
$60.00
High
$100.00
Mean
$81.08

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-06 main UBS Neutral → Neutral $78
2026-05-06 main Stifel Buy → Buy $90
2026-05-06 main Wells Fargo Equal-Weight → Equal-Weight $70
2026-05-06 main Keybanc Overweight → Overweight $93
2026-05-06 reit BTIG Buy → Buy $89
2026-04-27 main Keybanc Overweight → Overweight $92
2026-04-17 main Piper Sandler Overweight → Overweight $92
2026-03-24 init Rothschild & Co — → Sell $60
2026-02-27 main Wells Fargo Equal-Weight → Equal-Weight $83
2026-02-27 main Keybanc Overweight → Overweight $99
2026-02-27 reit BTIG Buy → Buy $100
2026-01-26 up Keybanc Sector Weight → Overweight $97
2026-01-20 up Mizuho Neutral → Outperform $100
2026-01-07 main Stifel Buy → Buy $105
2025-12-02 up BTIG Neutral → Buy $100
2025-11-10 main UBS Neutral → Neutral $79
2025-11-07 main Piper Sandler Overweight → Overweight $98
2025-10-01 init UBS — → Neutral $77
2025-09-15 main Wells Fargo Equal-Weight → Equal-Weight $82
2025-09-11 init Jefferies — → Hold $80
News
RSS: Latest SOLV news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-30 EISENBERG GLENN A Director — 3,403 — —
2026-04-30 HARRIS BERNARD A JR Director — 3,403 — —
2026-04-30 ALBAN CARLOS Director — 3,403 — —
2026-04-30 DEVORE SUSAN D Director — 3,403 — —
2026-04-30 WILSON DARRYL L Director — 3,403 — —
2026-04-30 MILY ELIZABETH Director — 3,403 — —
2026-04-30 WEILAND JOHN H Director — 3,403 — —
2026-04-30 COX CARRIE SMITH Director — 4,916 — —
2026-04-30 MAY KAREN J Director — 3,403 — —
2026-04-30 EDWARDS SHIRLEY ANN Director — 3,403 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
8,325.00
+0.86%
8,254.00
+0.70%
8,197.00
+0.82%
8,130.00
Operating Revenue
8,325.00
+0.86%
8,254.00
+0.70%
8,197.00
+0.82%
8,130.00
Cost Of Revenue
3,874.00
+5.82%
3,661.00
+4.48%
3,504.00
+2.01%
3,435.00
Reconciled Cost Of Revenue
3,874.00
+5.82%
3,661.00
+4.48%
3,504.00
+2.01%
3,435.00
Gross Profit
4,451.00
-3.09%
4,593.00
-2.13%
4,693.00
-0.04%
4,695.00
Operating Expense
3,819.00
+7.37%
3,557.00
+16.36%
3,057.00
+1.83%
3,002.00
Research And Development
739.00
-4.65%
775.00
+2.24%
758.00
-1.17%
767.00
Selling General And Administration
3,080.00
+10.71%
2,782.00
+21.01%
2,299.00
+2.86%
2,235.00
Total Expenses
7,693.00
+6.58%
7,218.00
+10.01%
6,561.00
+1.93%
6,437.00
Operating Income
632.00
-39.00%
1,036.00
-36.67%
1,636.00
-3.37%
1,693.00
Total Operating Income As Reported
2,181.00
+110.52%
1,036.00
-38.77%
1,692.00
-0.06%
1,693.00
EBITDA
2,549.00
+66.93%
1,527.00
-31.46%
2,228.00
-1.85%
2,270.00
Normalized EBITDA
1,082.00
-29.14%
1,527.00
-29.70%
2,172.00
-4.32%
2,270.00
Reconciled Depreciation
489.00
-11.89%
555.00
-1.07%
561.00
-2.94%
578.00
EBIT
2,060.00
+111.93%
972.00
-41.69%
1,667.00
-1.48%
1,692.00
Total Unusual Items
1,467.00
0.00
-100.00%
56.00
—
Total Unusual Items Excluding Goodwill
1,467.00
0.00
-100.00%
56.00
—
Special Income Charges
1,467.00
0.00
-100.00%
56.00
—
Other Special Charges
82.00
—
—
—
Net Income
1,556.00
+224.84%
479.00
-64.41%
1,346.00
+0.22%
1,343.00
Pretax Income
1,713.00
+183.14%
605.00
-63.71%
1,667.00
-1.48%
1,692.00
Net Non Operating Interest Income Expense
-347.00
+5.45%
-367.00
0.00
0.00
Interest Expense Non Operating
347.00
-5.45%
367.00
0.00
0.00
Net Interest Income
-347.00
+5.45%
-367.00
0.00
0.00
Interest Expense
347.00
-5.45%
367.00
0.00
0.00
Other Income Expense
1,428.00
+2331.25%
-64.00
-306.45%
31.00
+3200.00%
-1.00
Other Non Operating Income Expenses
-39.00
+39.06%
-64.00
-156.00%
-25.00
-2400.00%
-1.00
Gain On Sale Of Business
1,549.00
0.00
-100.00%
56.00
—
Tax Provision
157.00
+23.62%
127.00
-60.44%
321.00
-8.02%
349.00
Tax Rate For Calcs
0.00
-56.34%
0.00
+8.77%
0.00
-6.31%
0.00
Tax Effect Of Unusual Items
134.45
0.00
-100.00%
10.81
0.00
Net Income Including Noncontrolling Interests
1,556.00
+225.52%
478.00
-64.49%
1,346.00
+0.22%
1,343.00
Net Income From Continuing Operation Net Minority Interest
1,556.00
+224.84%
479.00
-64.41%
1,346.00
+0.22%
1,343.00
Net Income From Continuing And Discontinued Operation
1,556.00
+224.84%
479.00
-64.41%
1,346.00
+0.22%
1,343.00
Net Income Continuous Operations
1,556.00
+225.52%
478.00
-64.49%
1,346.00
+0.22%
1,343.00
Normalized Income
223.45
-53.35%
479.00
-63.18%
1,300.81
-3.14%
1,343.00
Net Income Common Stockholders
1,556.00
+224.84%
479.00
-64.41%
1,346.00
+0.22%
1,343.00
Diluted EPS
8.88
+221.74%
2.76
-64.59%
7.79
+0.17%
7.78
Basic EPS
8.94
+222.74%
2.77
-64.46%
7.79
+0.17%
7.78
Basic Average Shares
174.10
+0.52%
173.20
+0.28%
172.71
+0.01%
172.70
Diluted Average Shares
175.30
+0.92%
173.70
+0.57%
172.71
+0.01%
172.70
Diluted NI Availto Com Stockholders
1,556.00
+224.84%
479.00
-64.41%
1,346.00
+0.22%
1,343.00
Rent Expense Supplemental
—
—
481.00
-0.21%
482.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
14,294.00
-1.13%
14,457.00
+3.69%
13,943.00
+2.57%
13,594.00
Current Assets
3,859.00
+18.78%
3,249.00
+28.98%
2,519.00
+12.91%
2,231.00
Cash Cash Equivalents And Short Term Investments
878.00
+15.22%
762.00
+292.78%
194.00
+218.03%
61.00
Cash And Cash Equivalents
878.00
+15.22%
762.00
+292.78%
194.00
+218.03%
61.00
Receivables
1,184.00
-3.66%
1,229.00
-6.40%
1,313.00
+12.13%
1,171.00
Accounts Receivable
1,034.00
-0.96%
1,044.00
-20.49%
1,313.00
+12.13%
1,171.00
Gross Accounts Receivable
1,121.00
-0.80%
1,130.00
-19.00%
1,395.00
—
Allowance For Doubtful Accounts Receivable
-87.00
-1.16%
-86.00
-4.88%
-82.00
—
Inventory
1,066.00
+10.47%
965.00
+12.60%
857.00
-1.83%
873.00
Raw Materials
229.00
-2.97%
236.00
+1.29%
233.00
+0.43%
232.00
Work In Process
201.00
+5.79%
190.00
+11.11%
171.00
-1.16%
173.00
Finished Goods
636.00
+18.00%
539.00
+18.98%
453.00
-3.21%
468.00
Prepaid Assets
174.00
+0.58%
173.00
—
—
Other Current Assets
557.00
+364.17%
120.00
-22.58%
155.00
+23.02%
126.00
Total Non Current Assets
10,436.00
-6.89%
11,208.00
-1.89%
11,424.00
+0.54%
11,363.00
Net PPE
1,326.00
-18.25%
1,622.00
+11.32%
1,457.00
+10.46%
1,319.00
Gross PPE
3,193.00
-11.55%
3,610.00
+8.15%
3,338.00
+8.03%
3,090.00
Accumulated Depreciation
-1,867.00
+6.09%
-1,988.00
-5.69%
-1,881.00
-6.21%
-1,771.00
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
870.00
-9.00%
956.00
+2.03%
937.00
+9.46%
856.00
Machinery Furniture Equipment
1,824.00
-15.16%
2,150.00
+3.32%
2,081.00
+5.90%
1,965.00
Construction In Progress
499.00
-0.99%
504.00
+57.50%
320.00
+33.33%
240.00
Other Properties
—
—
1,466.00
+4955.17%
29.00
Goodwill And Other Intangible Assets
8,296.00
-7.01%
8,921.00
-5.47%
9,437.00
-2.57%
9,686.00
Goodwill
5,704.00
-10.55%
6,377.00
-2.42%
6,535.00
+1.57%
6,434.00
Other Intangible Assets
2,592.00
+1.89%
2,544.00
-12.34%
2,902.00
-10.76%
3,252.00
Other Non Current Assets
814.00
+22.41%
665.00
+25.47%
530.00
+48.04%
358.00
Total Liabilities Net Minority Interest
9,244.00
-19.60%
11,498.00
+404.96%
2,277.00
+22.95%
1,852.00
Current Liabilities
3,136.00
+16.02%
2,703.00
+56.42%
1,728.00
+31.81%
1,311.00
Payables And Accrued Expenses
1,561.00
+22.72%
1,272.00
+61.22%
789.00
+52.91%
516.00
Payables
1,318.00
+30.24%
1,012.00
+73.58%
583.00
+67.53%
348.00
Accounts Payable
687.00
+11.17%
618.00
+29.56%
477.00
+37.07%
348.00
Current Accrued Expenses
243.00
-6.54%
260.00
+26.21%
206.00
+22.62%
168.00
Employee Benefits
363.00
+3.71%
350.00
+110.84%
166.00
+82.42%
91.00
Pensionand Other Post Retirement Benefit Plans Current
320.00
+13.88%
281.00
+34.45%
209.00
+221.54%
65.00
Total Tax Payable
196.00
+60.66%
122.00
+15.09%
106.00
—
Current Debt And Capital Lease Obligation
—
200.00
—
—
Current Debt
—
200.00
—
—
Other Current Borrowings
—
200.00
—
—
Current Deferred Liabilities
621.00
+8.57%
572.00
-0.35%
574.00
+2.68%
559.00
Current Deferred Revenue
621.00
+8.57%
572.00
-0.35%
574.00
+2.68%
559.00
Other Current Liabilities
634.00
+67.72%
378.00
+142.31%
156.00
-8.77%
171.00
Total Non Current Liabilities Net Minority Interest
6,108.00
-30.55%
8,795.00
+1502.00%
549.00
+1.48%
541.00
Long Term Debt And Capital Lease Obligation
5,035.00
-35.53%
7,810.00
-5.94%
8,303.00
—
Long Term Debt
5,035.00
-35.53%
7,810.00
-5.94%
8,303.00
—
Non Current Pension And Other Postretirement Benefit Plans
363.00
+3.71%
350.00
+110.84%
166.00
+82.42%
91.00
Non Current Deferred Liabilities
164.00
-27.11%
225.00
-2.60%
231.00
+7.44%
215.00
Non Current Deferred Taxes Liabilities
164.00
-27.11%
225.00
-2.60%
231.00
+7.44%
215.00
Other Non Current Liabilities
546.00
+33.17%
410.00
+169.74%
152.00
-35.32%
235.00
Stockholders Equity
5,050.00
+70.67%
2,959.00
-74.64%
11,666.00
-0.65%
11,742.00
Common Stock Equity
5,050.00
+70.67%
2,959.00
-74.64%
11,666.00
-0.65%
11,742.00
Capital Stock
2.00
+0.00%
2.00
0.00
—
Common Stock
2.00
+0.00%
2.00
0.00
—
Share Issued
173.49
+0.41%
172.79
+0.04%
172.71
+0.00%
172.71
Ordinary Shares Number
173.49
+0.41%
172.79
+0.04%
172.71
+0.00%
172.71
Additional Paid In Capital
3,876.00
+2.78%
3,771.00
0.00
—
Retained Earnings
1,797.00
+642.56%
242.00
0.00
—
Gains Losses Not Affecting Retained Earnings
-625.00
+40.81%
-1,056.00
-213.35%
-337.00
+32.19%
-497.00
Other Equity Adjustments
-625.00
+40.81%
-1,056.00
-213.35%
-337.00
—
Total Equity Gross Minority Interest
5,050.00
+70.67%
2,959.00
-74.64%
11,666.00
-0.65%
11,742.00
Total Capitalization
10,085.00
-6.35%
10,769.00
-7.69%
11,666.00
-0.65%
11,742.00
Working Capital
723.00
+32.42%
546.00
-30.97%
791.00
-14.02%
920.00
Invested Capital
10,085.00
-8.06%
10,969.00
-5.97%
11,666.00
-0.65%
11,742.00
Total Debt
5,035.00
-37.14%
8,010.00
-3.53%
8,303.00
—
Net Debt
4,157.00
-42.65%
7,248.00
-5.91%
7,703.00
—
Net Tangible Assets
-3,246.00
+45.56%
-5,962.00
-367.47%
2,229.00
+8.41%
2,056.00
Tangible Book Value
-3,246.00
+45.56%
-5,962.00
-367.47%
2,229.00
+8.41%
2,056.00
Duefrom Related Parties Current
150.00
-18.92%
185.00
0.00
—
Dueto Related Parties Current
435.00
+59.93%
272.00
0.00
—
Foreign Currency Translation Adjustments
—
—
—
-504.00
Interest Payable
71.00
-37.72%
114.00
0.00
—
Minimum Pension Liabilities
—
—
—
7.00
Other Equity Interest
—
—
12,003.00
-1.93%
12,239.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
369.00
-68.86%
1,185.00
-38.12%
1,915.00
+14.06%
1,679.00
Cash Flow From Continuing Operating Activities
369.00
-68.86%
1,185.00
-38.12%
1,915.00
+14.06%
1,679.00
Net Income From Continuing Operations
1,556.00
+224.84%
479.00
-64.41%
1,346.00
+0.22%
1,343.00
Depreciation Amortization Depletion
489.00
-11.89%
555.00
-1.07%
561.00
-2.94%
578.00
Depreciation And Amortization
489.00
-11.89%
555.00
-1.07%
561.00
-2.94%
578.00
Other Non Cash Items
-111.00
—
—
—
Pension And Employee Benefit Expense
62.00
+82.35%
34.00
-17.07%
41.00
-35.94%
64.00
Stock Based Compensation
161.00
+43.75%
112.00
+187.18%
39.00
+5.41%
37.00
Deferred Tax
-120.00
+22.58%
-155.00
-9.15%
-142.00
-0.71%
-141.00
Deferred Income Tax
-120.00
+22.58%
-155.00
-9.15%
-142.00
-0.71%
-141.00
Operating Gains Losses
-1,487.00
-4473.53%
34.00
+326.67%
-15.00
-123.44%
64.00
Change In Working Capital
-119.00
-174.38%
160.00
+26.98%
126.00
+162.38%
-202.00
Change In Receivables
78.00
-71.74%
276.00
+313.95%
-129.00
-303.13%
-32.00
Changes In Account Receivables
34.00
-20.93%
43.00
+133.33%
-129.00
-303.13%
-32.00
Change In Inventory
-139.00
-5.30%
-132.00
-673.91%
23.00
+128.05%
-82.00
Change In Payables And Accrued Expense
136.00
+366.67%
-51.00
-120.65%
247.00
+888.00%
25.00
Change In Accrued Expense
43.00
-44.87%
78.00
-45.07%
142.00
—
Change In Payable
93.00
+172.09%
-129.00
-222.86%
105.00
+320.00%
25.00
Change In Account Payable
104.00
-60.90%
266.00
+153.33%
105.00
+320.00%
25.00
Change In Other Working Capital
-194.00
-389.55%
67.00
+546.67%
-15.00
+86.73%
-113.00
Change In Other Current Liabilities
—
—
137.00
+235.64%
-101.00
Investing Cash Flow
2,797.00
+836.05%
-380.00
-65.22%
-230.00
+9.09%
-253.00
Cash Flow From Continuing Investing Activities
2,797.00
+836.05%
-380.00
-65.22%
-230.00
+9.09%
-253.00
Net PPE Purchase And Sale
-379.00
+0.26%
-380.00
-31.03%
-290.00
-15.54%
-251.00
Purchase Of PPE
-379.00
+0.26%
-380.00
-31.03%
-290.00
-15.54%
-251.00
Capital Expenditure
-379.00
+0.26%
-380.00
-31.03%
-290.00
-15.54%
-251.00
Net Investment Purchase And Sale
—
—
—
0.00
Sale Of Investment
—
—
—
0.00
Net Business Purchase And Sale
3,194.00
0.00
-100.00%
60.00
0.00
Purchase Of Business
-696.00
0.00
0.00
—
Gain Loss On Sale Of Business
-1,549.00
0.00
+100.00%
-56.00
0.00
Net Other Investing Changes
-18.00
—
—
-2.00
Financing Cash Flow
-3,057.00
-1173.75%
-240.00
+84.54%
-1,552.00
-6.30%
-1,460.00
Cash Flow From Continuing Financing Activities
-3,057.00
-1173.75%
-240.00
+84.54%
-1,552.00
-6.30%
-1,460.00
Net Issuance Payments Of Debt
-3,070.00
-138.36%
8,003.00
0.00
0.00
Issuance Of Debt
0.00
-100.00%
8,303.00
0.00
0.00
Repayment Of Debt
-3,070.00
-923.33%
-300.00
0.00
0.00
Long Term Debt Issuance
0.00
-100.00%
8,303.00
0.00
0.00
Long Term Debt Payments
-3,070.00
-923.33%
-300.00
0.00
0.00
Net Long Term Debt Issuance
-3,070.00
-138.36%
8,003.00
0.00
0.00
Net Other Financing Charges
13.00
+100.16%
-8,243.00
-431.12%
-1,552.00
-6.30%
-1,460.00
Changes In Cash
109.00
-80.71%
565.00
+324.81%
133.00
+491.18%
-34.00
Effect Of Exchange Rate Changes
7.00
+133.33%
3.00
0.00
-100.00%
4.00
Beginning Cash Position
762.00
+292.78%
194.00
+218.03%
61.00
-32.97%
91.00
End Cash Position
878.00
+15.22%
762.00
+292.78%
194.00
+218.03%
61.00
Free Cash Flow
-10.00
-101.24%
805.00
-50.46%
1,625.00
+13.80%
1,428.00
Interest Paid Supplemental Data
181.00
-36.93%
287.00
0.00
0.00
Income Tax Paid Supplemental Data
181.00
-25.82%
244.00
0.00
0.00
Sale Of Business
3,890.00
0.00
-100.00%
60.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category